How we help patients

Volv Global Case Studies

We’ve helped many of the top pharma companies with tailored, data-driven insights on disease phenomenology to support getting patients personalised treatment faster. Find out how.

Black and white portrait of a woman with straight dark hair, wearing a textured knitted sweater and facing the camera with a calm expression.
All
Case Studies

Advocacy in rare disease: Driving technology advances – 2023 Webinar

Volv Global at Faces of Industrial Research 2026

Uncovering the uncommon: Advances in Rare Disease diagnosis – 2024 Podcast

Chronic Obstructive Pulmonary Disease: Why We Need Better Patient Identification for 21st-Century Treatments

The Patient Voice and AI-Driven Healthcare – Guest Article by Rare Patient Voice

Volv Global at the Digital Lounge @Davos 2026

MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification

Bridging gaps across the CLL care pathway – Part 2: Knowing When To Treat

Bridging gaps across the CLL care pathway – Part 1: From Signal to Stratification